Cigna Group $CI Shares Sold by Brighton Jones LLC

Brighton Jones LLC lowered its position in Cigna Group (NYSE:CI) by 39.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,469 shares of the health services provider’s stock after selling 2,864 shares during the quarter. Brighton Jones LLC’s holdings in Cigna Group were worth $1,215,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CI. BlackRock Inc. grew its position in shares of Cigna Group by 3.7% during the second quarter. BlackRock Inc. now owns 23,438,250 shares of the health services provider’s stock worth $6,461,457,000 after acquiring an additional 840,098 shares during the last quarter. GQG Partners LLC acquired a new position in shares of Cigna Group in the 2nd quarter valued at $1,628,918,000. Bank of America Corp DE raised its position in Cigna Group by 8.8% in the 1st quarter. Bank of America Corp DE now owns 3,182,083 shares of the health services provider’s stock valued at $848,821,000 after purchasing an additional 256,677 shares during the last quarter. Dimensional Fund Advisors LP raised its position in Cigna Group by 10.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 2,426,218 shares of the health services provider’s stock valued at $647,008,000 after purchasing an additional 236,340 shares during the last quarter. Finally, Legal & General Group Plc purchased a new stake in Cigna Group in the 2nd quarter valued at $542,779,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Price Performance

Cigna Group stock opened at $302.30 on Wednesday. Cigna Group has a 12 month low of $257.85 and a 12 month high of $318.05. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.74. The business has a 50 day simple moving average of $286.66 and a 200-day simple moving average of $282.38. The stock has a market capitalization of $79.88 billion, a PE ratio of 13.34, a price-to-earnings-growth ratio of 1.10 and a beta of 0.25.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, November 5th. The health services provider reported $7.98 earnings per share for the quarter, beating analysts’ consensus estimates of $7.52 by $0.46. The firm had revenue of $73.79 billion for the quarter, compared to analyst estimates of $72.64 billion. Cigna Group had a net margin of 2.09% and a return on equity of 19.57%. Cigna Group’s quarterly revenue was up 5.6% on a year-over-year basis. During the same period last year, the firm posted $7.83 EPS. Equities analysts predict that Cigna Group will post 30.70 earnings per share for the current year.

Cigna Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, December 17th. Stockholders of record on Thursday, December 3rd will be paid a $1.56 dividend. This represents a $6.24 annualized dividend and a dividend yield of 2.1%. The ex-dividend date is Thursday, December 3rd. Cigna Group’s dividend payout ratio (DPR) is 27.54%.

Key Stories Impacting Cigna Group

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Recent coverage says strong Q3 growth has lifted Cigna’s 2026 earnings outlook, offering a favorable signal about business performance and the company’s earnings trajectory. The Cigna Group stock: Higher outlook follows strong Q3 performance
• Positive Sentiment: Barclays raised its price target to $320 from $310, implying potential upside from the referenced $302.30 price. However, it maintained an “equal weight” rating, indicating a balanced rather than strongly bullish view. Barclays price target update
• Neutral Sentiment: The Cigna Group Foundation awarded $3.45 million to 23 nonprofits supporting housing stability and mental health for veterans and their families. This highlights community investment but is not likely to have a significant direct effect on earnings. Cigna Foundation veteran grants
• Neutral Sentiment: Cigna’s CFO is scheduled to speak at the UBS Global Healthcare Conference, which could provide investors with updates but is not itself a financial announcement. UBS Global Healthcare Conference appearance
• Neutral Sentiment: Cigna Healthcare Hong Kong is expanding access to Headspace’s self-guided mental-wellbeing resources. The partnership may support its service offering, though the report provides no financial impact. Headspace resources in Hong Kong
• Negative Sentiment: Guggenheim cut its price target for Cigna, a cautious counterpoint to Barclays’ increase. The report provided here does not specify the revised target or rating. Guggenheim price target update

Analyst Ratings Changes

A number of analysts recently weighed in on CI shares. Jefferies Financial Group cut shares of Cigna Group from a “buy” rating to a “hold” rating and decreased their price target for the stock from $336.00 to $307.00 in a research note on Tuesday, August 4th. Barclays upped their target price on shares of Cigna Group from $310.00 to $320.00 and gave the company an “equal weight” rating in a report on Monday. Robert W. Baird set a $362.00 target price on shares of Cigna Group in a research note on Friday, July 31st. Raymond James Financial downgraded shares of Cigna Group from a “strong-buy” rating to an “outperform” rating and decreased their target price for the stock from $350.00 to $320.00 in a research note on Monday, August 3rd. Finally, Wall Street Zen raised Cigna Group from a “hold” rating to a “buy” rating in a report on Sunday. Fourteen research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $336.20.

Insider Activity

In related news, insider Everett Neville sold 617 shares of the stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total transaction of $175,258.85. Following the completion of the transaction, the insider directly owned 5,053 shares of the company’s stock, valued at $1,435,304.65. This represents a 10.88% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole S. Jones sold 2,677 shares of the firm’s stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total transaction of $748,515.97. Following the completion of the sale, the insider owned 25,880 shares of the company’s stock, valued at approximately $7,236,306.80. The trade was a 9.37% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by insiders.

Cigna Group Company Profile

The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members. Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.